Evidence map›Paper›PMID 41073095›Full record

ArticleBMJ open quality2025

Improving colorectal cancer screening through Cologuard education: a quality improvement initiative in an urban primary care clinic.

Mako Koseki Senda, Desiree Chow, Bharati Dev, Jake DeBroff, Caroline O' Ferrall, Ryan Fliehman, Rui Jiang

Abstract read
In one paragraph

Article in BMJ open quality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mako Koseki SendaMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.ORCID 0000-0001-5385-8527
Desiree ChowMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.
Bharati DevMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.
Jake DeBroffMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.
Caroline O' FerrallMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.
Ryan FliehmanMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA.
Rui JiangMount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai Department of Medicine, New York, New York, USA Rui.jiang@mssm.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveColorectal cancer (CRC) screening is critical for early detection and prevention. A prior analysis at our urban primary care clinic revealed a CRC screening completion rate of 62% in patients who had visited our clinic in the first half of 2023. Identified barriers for lower-than-national-average CRC screening rate included limited awareness and understanding among both providers and patients regarding CRC screening options and processes, particularly Cologuard. To address these gaps effectively, we implemented a series of targeted interventions aimed at increasing Cologuard utilisation.

methodsUsing an iterative plan-do-study-act model, interventions were implemented from January to September 2024 among average-risk patients aged 45-75 years who presented to primary care visits. Interventions focused on (1) biweekly, small-group provider education sessions with daily reminders, (2) bilingual patient-facing educational materials, posters and instructional videos and (3) electronic medical record portal outreach. The primary outcome was Cologuard completion rate among CRC-screening eligible patients. Process measures were Cologuard order rates and kit return rates, and the secondary outcome was the overall CRC screening completion rates.

resultsA total of 2171 CRC-screening eligible patients visited during the intervention period, and a total of 399 Cologuard orders were placed, with 235 completed kits returned. Cologuard completion rates improved from a preintervention median of 7.38%-10.00%. Median order rates rose from 14.59% to 18.71%, and overall CRC screening rates increased from 68.6% to 72.2%. Direct patient messaging had the most immediate impact, with 7.2% responses by recipients, resulting in 16 screenings and a transient peak of 20.71% in monthly Cologuard completion. DISCUSSION: This project demonstrates that practical, multifaceted, low-cost strategies of provider-focused education and patient-directed digital outreach can significantly improve Cologuard usage, ultimately leading to an increase in CRC screening completion rates. Sustained reinforcement and improvement in kit return will be a key to future improvements.

Indexed as

Colorectal NeoplasmsEarly Detection of CancerMass ScreeningAgedFemaleHumansMaleMiddle AgedPrimary Health CareQuality ImprovementCOLORECTAL CANCERContinuity of Patient CareContinuous quality improvementPrimary care

Identifiers

PMID41073095
PMCPMC12517030

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.